# Feasibility, Reliability, and Satisfaction of CEA Using Home Based (Automated) Capillary Blood Sampling

> **NCT05646030** · NA · COMPLETED · sponsor: **Erasmus Medical Center** · enrollment: 102 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DIAGNOSTIC_TEST:** TAP-II
- **DIAGNOSTIC_TEST:** Lancet capillary sampling
- **DIAGNOSTIC_TEST:** Venipuncture

## Key facts

- **NCT ID:** NCT05646030
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-25
- **Primary completion:** 2024-08-26
- **Final completion:** 2024-08-26
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2024-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05646030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05646030, "Feasibility, Reliability, and Satisfaction of CEA Using Home Based (Automated) Capillary Blood Sampling". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05646030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*